Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-18

Clinical Trial Update: Rhodiola Rosea Therapy of Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Rhodiola rosea therapy for depression has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhodiola rosea therapy

Snippet

Sponsor: University of Pennsylvania | Conditions: Depression | Phase 3 | Status: COMPLETED | Results posted: 2016-05-18